Precision Biosciences (DTIL) Change in Account Payables (2018 - 2026)
Precision Biosciences' (DTIL) quarterly Change in Account Payables came in at $648000.0 in Q1 2026, up 711.32% year-on-year from $79869.8 in Q1 2025, and up 161.71% on a QoQ basis from -$1.0 million in Q4 2025.
Precision Biosciences (DTIL) Change in Account Payables (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 9 years of Change in Account Payables data on file, last reported at $648000.0 in Q1 2026.
- On a quarterly basis, Change in Account Payables rose 711.32% year-over-year to $648000.0 in Q1 2026; TTM through Mar 2026 was $17000.0, a 117.0% increase from a year earlier, with the FY2025 full-year figure at -$737000.0, up 64.84% from the prior year.
- Change in Account Payables for Q1 2026 stood at $648000.0, up from -$1.0 million in the prior quarter.
- Over the last five years, Change in Account Payables for DTIL reached as high as $2.0 million in Q4 2023 and fell as low as -$2.1 million in Q1 2024.
- Historically, Change in Account Payables has averaged -$30823.5 across 5 years, with a median of $72000.0 in 2024.
- Across the five-year window, Change in Account Payables plunged 1558.33% in 2025 and soared 711.32% in 2026, its largest moves.
- Year by year, Change in Account Payables stood at $340000.0 in 2022, then surged by 489.12% to $2.0 million in 2023, then sank by 96.41% to $72000.0 in 2024, then tumbled by 1558.33% to -$1.0 million in 2025, then soared by 161.71% to $648000.0 in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were $648000.0 in Q1 2026, -$1.0 million in Q4 2025, and $220000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -42.19 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 16.86 Mn |
| 10 | Precision Biosciences | 178.85 Mn | 150.56 Mn | - | 648,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 648,000.00 |
| Mar 31, 2026 | 648,000.00 |
| Dec 31, 2025 | -1.05 Mn |
| Dec 31, 2025 | -1.05 Mn |
| Sep 30, 2025 | 220,000.00 |
| Sep 30, 2025 | 220,000.00 |
| Jun 30, 2025 | 199,000.00 |
| Jun 30, 2025 | 199,000.00 |
| Mar 31, 2025 | -106,000.00 |
| Mar 31, 2025 | -106,000.00 |
| Dec 31, 2024 | 72,000.00 |
| Dec 31, 2024 | 72,000.00 |
| Sep 30, 2024 | -186,000.00 |
| Sep 30, 2024 | -186,000.00 |
| Jun 30, 2024 | 120,000.00 |
| Jun 30, 2024 | 120,000.00 |
| Mar 31, 2024 | -2.10 Mn |
| Mar 31, 2024 | -2.10 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Dec 31, 2023 | 2.00 Mn |